{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:11:10Z","timestamp":1782994270611,"version":"3.54.5"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Sepsis is a clinical syndrome characterized by a dysregulated response to infection. It represents a leading cause of mortality in ICU patients worldwide. Although sepsis is in the point of interest of research for several decades, its clinical management and patient survival are improving slowly. Monitoring of the biomarkers and their combinations could help in early diagnosis, estimation of prognosis and patient's stratification and response to the treatment. Circulating soluble endoglin (sEng) is the cleaved extracellular part of transmembrane glycoprotein endoglin. As a biomarker, sEng has been tested in several pathologic conditions where its elevation was associated with endothelial dysfunction. In this study we have tested the ability of sEng to predict mortality and its correlation with other clinical characteristics in the cohort of septic shock patients (<jats:italic>n<\/jats:italic>= 37) and patients with severe COVID-19 (<jats:italic>n<\/jats:italic>= 40). In patients with COVID-19 sEng did not predict mortality or correlate with markers of organ dysfunction. In contrast, in septic shock the level of sEng was significantly higher in patients with early mortality (<jats:italic>p<\/jats:italic>= 0.019; AUC = 0.801). Moreover, sEng levels correlated with signs of circulatory failure (required dose of noradrenalin and lactate levels;<jats:italic>p<\/jats:italic>= 0.002 and 0.016, respectively). The predominant clinical problem in patients with COVID-19 was ARDS, and although they often showed signs of other organ dysfunction, circulatory failure was exceptional. This potentially explains the difference between sEng levels in COVID-19 and septic shock. In conclusion, we have confirmed that sEng may reflect the extent of the circulatory failure in septic shock patients and thus could be potentially used for the early identification of patients with the highest degree of endothelial dysfunction who would benefit from endothelium-targeted individualized therapy.<\/jats:p>","DOI":"10.3389\/fmed.2022.972040","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T05:00:00Z","timestamp":1661922000000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Prognostic value of soluble endoglin in patients with septic shock and severe COVID-19"],"prefix":"10.3389","volume":"9","author":[{"given":"Veronika","family":"Tom\u00e1\u0161kov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"M\u00fdtnikov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Hortov\u00e1 Kohoutkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Mrkva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Skot\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"\u0160itina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate\u0159ina","family":"Hel\u00e1nov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Fri\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Pa\u0159enica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladim\u00edr","family":"\u0160r\u00e1mek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hel\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"J Am Medical Assoc."},{"key":"B2","doi-asserted-by":"publisher","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat Rev Dis Prim."},{"key":"B3","doi-asserted-by":"publisher","first-page":"215376","DOI":"10.3390\/ijms20215376","article-title":"The pathogenesis of sepsis and potential therapeutic targets","volume":"20","author":"Huang","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/SHK.0000000000001541","article-title":"Phagocytosis-inflammation crosstalk in sepsis: new avenues for therapeutic intervention","volume":"54","author":"Hortov\u00e1-Kohoutkov\u00e1","year":"2020","journal-title":"Shock."},{"key":"B5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41581-019-0199-3","article-title":"Prognostic and predictive enrichment in sepsis","volume":"16","author":"Stanski","year":"2020","journal-title":"Nat Rev Nephrol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"J Am Medical Assoc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0255999","article-title":"COVID-19 severity: Studying the clinical and demographic risk factors for adverse outcomes","volume":"16","author":"Shoaib","year":"2021","journal-title":"PLoS ONE."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1093\/cvr\/cvaa230","article-title":"Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science","volume":"116","author":"Evans","year":"2020","journal-title":"Cardiovasc Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.02147","article-title":"Epidemiology and immune pathogenesis of viral sepsis","volume":"9","author":"Lin","year":"2018","journal-title":"Front Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.3906\/sag-2108-239","article-title":"COVID-19 and Sepsis","volume":"51","author":"Ko\u00e7ak Tufan","year":"2021","journal-title":"Turk J Med Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/sji.13125","article-title":"High CD4-to-CD8 ratio identifies an at-risk population susceptible to lethal COVID-19","volume":"2021","author":"de Zuani","year":"2021","journal-title":"Scand J Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2019.00010","article-title":"Endoglin as an adhesion molecule in mature and progenitor endothelial cells: a function beyond TGF-\u03b2","volume":"6","author":"Rossi","year":"2019","journal-title":"Frontiers in Medicine."},{"key":"B13","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4049\/jimmunol.134.2.1276","article-title":"Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies","volume":"134","author":"Quackenbush","year":"1985","journal-title":"J Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21239247","article-title":"Endoglin: an \u2018accessory' receptor regulating blood cell development and inflammation","volume":"21","author":"Meurer","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1182\/blood-2012-06-435347","article-title":"Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration","volume":"121","author":"Rossi","year":"2013","journal-title":"Blood."},{"key":"B16","doi-asserted-by":"publisher","first-page":"15468","DOI":"10.1073\/pnas.202614899","article-title":"Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells","volume":"99","author":"Chen","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1177\/1358863X18767761","article-title":"Life expectancy and comorbidities in patients with hereditary hemorrhagic telangiectasia","volume":"23","author":"Droege","year":"2018","journal-title":"Vasc Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10456-016-9495-8","article-title":"Transcription factor KLF6 upregulates expression of metalloprotease MMP14 and subsequent release of soluble endoglin during vascular injury","volume":"19","author":"Gallardo-Vara","year":"2016","journal-title":"Angiogenesis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms222011282","article-title":"Generation of a soluble form of human endoglin fused to green fluorescent protein","volume":"22","author":"Ruiz-Llorente","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1158\/0008-5472.CAN-09-4466","article-title":"Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis","volume":"70","author":"Hawinkels","year":"2010","journal-title":"Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.lfs.2017.03.014","article-title":"Soluble endoglin modulates the pro-inflammatory mediators NF-\u03baB and IL-6 in cultured human endothelial cells","volume":"175","author":"Varejckova","year":"2017","journal-title":"Life Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1096\/fj.201802245R","article-title":"Regulation and role of endoglin in cholesterol-induced endothelial and vascular dysfunction in vivo and in vitro","volume":"33","author":"Vicen","year":"2019","journal-title":"FASEB J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2015.10.003","article-title":"Soluble endoglin, hypercholesterolemia and endothelial dysfunction","volume":"243","author":"Rathouska","year":"2015","journal-title":"Atherosclerosis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antiox11040640","article-title":"Kinetics of biomarkers of oxidative stress in septic shock: a pilot study","volume":"11","author":"Helan","year":"2022","journal-title":"Antioxidants."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1002\/ctm2.283","article-title":"Time course of endothelial dysfunction markers and mortality in COVID-19 patients: a pilot study","volume":"11","author":"Vieceli Dalla Sega","year":"2021","journal-title":"Clin Transl Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1097\/CCM.0000000000005357","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/cvr\/cvaa070","article-title":"The effects of sepsis on endothelium and clinical implications","volume":"117","author":"Dolmatova","year":"2021","journal-title":"Cardiovasc Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jcrc.2017.07.034","article-title":"Circulating levels of the angiogenesis mediators endoglin, HB-EGF, BMP-9 and FGF-2 in patients with severe sepsis and septic shock","volume":"42","author":"Faiotto","year":"2017","journal-title":"J Crit Care."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0145181","article-title":"Lactate clearance and vasopressor seem to be predictors for mortality in severe sepsis patients with lactic acidosis supplementing sodium bicarbonate: a retrospective analysis","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS ONE."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1113\/EP089474","article-title":"The role of lactate in sepsis and COVID-19: perspective from contracting skeletal muscle metabolism","volume":"2021","author":"Iepsen","year":"2021","journal-title":"Exp Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"104224","DOI":"10.1016\/j.mvr.2021.104224","article-title":"Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis","volume":"138","author":"Andrianto","year":"2021","journal-title":"Microvasc Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1161\/CIRCRESAHA.119.315974","article-title":"Loss of endothelial endoglin promotes high-output heart failure through peripheral arteriovenous shunting driven by VEGF signaling","volume":"2020","author":"Tual-Chalot","year":"2020","journal-title":"Circul Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.amjcard.2010.08.018","article-title":"Usefulness of soluble endoglin as a noninvasive measure of left ventricular filling pressure in heart failure","volume":"106","author":"Kapur","year":"2010","journal-title":"Am J Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1096\/fasebj.14.1.55","article-title":"CD105 antagonizes the inhibitory signaling of transforming growth factor \u03b2l on human vascular endothelial cells","volume":"14","author":"Li","year":"2000","journal-title":"FASEB J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-01993-w","article-title":"Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment","volume":"7","author":"Hannan","year":"2017","journal-title":"Sci Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ajog.2015.12.019","article-title":"Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction","volume":"214","author":"Brownfoot","year":"2016","journal-title":"Am J Obstetr Gynecol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.22074\/cellj.2020.6286","article-title":"Review on the protective effects of metformin in sepsis-induced organ failure","volume":"21","author":"Hassan","year":"2020","journal-title":"Cell J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2022.821358","article-title":"Resveratrol: potential application in sepsis","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1007\/s00018-020-03701-w","article-title":"Membrane and soluble endoglin role in cardiovascular and metabolic disorders related to metabolic syndrome","volume":"78","author":"Vicen","year":"2021","journal-title":"Cell Mol Life Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.mefs.2018.07.003","article-title":"Influence of obesity on soluble endoglin and transforming growth factor \u03b21 in women with polycystic ovary syndrome","volume":"23","author":"Rashad","year":"2018","journal-title":"Middle East Fertil Soc J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/iju.12719","article-title":"Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy","volume":"22","author":"Fujita","year":"2015","journal-title":"Int J Urol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40560-019-0383-3","article-title":"Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan","volume":"7","author":"Abe","year":"2019","journal-title":"J Intensive Care."},{"key":"B44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/0003319720903586","article-title":"Novel biomarkers for evaluation of endothelial dysfunction","volume":"71","author":"Leite","year":"2020","journal-title":"Angiology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/14728222.2021.1988928","article-title":"Endothelial dysfunction: a therapeutic target in bacterial sepsis?","volume":"25","author":"Vincent","year":"2021","journal-title":"Expert Opin Ther Targets."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.972040\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T17:33:49Z","timestamp":1676568829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.972040\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,31]]},"references-count":45,"alternative-id":["10.3389\/fmed.2022.972040"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.972040","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,31]]},"article-number":"972040"}}